Updated: Jun 7, 2026

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
1The Paul Strickland Scanner Centre, Mount Vernon Hospital, Northwood, Middlesex HA6 2RN, UK. wai-lup.wong@paul.strickland-scannercentre.org.uk
Incidental prostate fluorodeoxyglucose (FDG) uptake is rare in prostate cancer. Even with FDG-avid lesions, cancer is unlikely, guiding management strategies for this uncommon finding.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: